Slow skeletal muscle fiber (Type I fiber)

Slow skeletal muscle fibers, also known as Type I or slow-twitch fibers, are specialized muscle cells optimized for endurance and fatigue resistance through high mitochondrial density and aerobic metabolism (StatPearls, 2023). These fibers are defined by the expression of specific molecular components, including Myosin Heavy Chain 7 (MYH7) and slow skeletal troponin isoforms (TNNI1, TNNT1), which govern their slow contraction velocity and high efficiency (UniProt, 2024). While the fiber itself is a cellular structure rather than a single molecular target, its unique proteome is the focus of therapeutic intervention for conditions like sarcopenia, heart failure, and neuromuscular disorders (PubMed, 2022). For instance, drugs like Omecamtiv mecarbil target the MYH7 motor protein to improve contractility, though this isoform is shared with cardiac muscle, leading to potential safety concerns regarding cardiac specificity (PubChem, 2024). Understanding the distinct physiological and molecular profile of these fibers is essential for developing treatments that enhance physical performance or mitigate muscle wasting (NIH, 2023). These fibers play a critical role in maintaining posture and performing low-intensity, long-duration activities (StatPearls, 2023). Research into fiber-type switching also explores how pharmacological agents can shift muscle composition to improve metabolic health (PubMed, 2021).

Other names

Type I muscle fiberSlow-twitch muscle fiberSlow oxidative fiberRed muscle fiberSO fiber

Activation or modulation of slow-twitch specific contractile proteins, such as the Myosin Heavy Chain 7 (MYH7) motor protein or the slow skeletal troponin complex, to enhance force production or calcium sensitivity.